Manipal Health Enterprises Limited (NSE:MANIPALHOS)

India · Delayed Price · Currency is INR

699.15

+8.65 (1.25%)

Oct 7, 2026, 3:30 PM IST

Manipal Health Enterprises Earnings Call Transcripts

Fiscal Year 2027

Q1 26/27
Q1 saw robust 38% revenue growth, strong EBITDA, and margin resilience driven by volume and specialty mix. Digital health and new capacity additions contributed significantly, while integration of acquisitions and greenfield ramp-up are expected to further boost margins and growth.

Read full transcript →

Quarterly report
Slides